Heavy cost of Aetna acquisition weighed heavily the past year, despite fairly strong earnings. Although a judge is re-verifying the federally greenlighted merger, posing downside risk, the merger will likely continue through.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.